AHK-Cu and GHK-Cu: Copper-Peptide Identity Before Biological Comparison
AHK-Cu and GHK-Cu are different copper complexes: AHK contains alanine–histidine–lysine, while GHK contains glycine–histidine–lysine. The shared copper-peptide label does not make them interchangeable. Their chemical identities, published experiments, and analytical results must be evaluated separately, especially when a paper about one is used to explain the other.
One letter changes the molecule
The abbreviations describe amino-acid sequences, not grades of the same ingredient. A stands for alanine and G for glycine. Both sequences contain histidine and lysine, but changing the first residue changes the peptide ligand. Adding “Cu” identifies a copper-complex context; it is not simply a marketing suffix.
This distinction is visible in the separate AHK-Cu and GHK-Cu entries. The useful comparison starts with those identities, before considering broader research themes such as extracellular matrix biology or cultured follicle responses.
A copper peptide is a coordination complex in which a peptide provides binding groups for copper. Knowing the peptide sequence is necessary, but a complete experimental description also identifies the metal, preparation, and measurement conditions. Our explanation of GHK-Cu coordination chemistry develops that chemical distinction.
Four labels that should stay separate
| Label | What the name identifies | What should not be assumed |
|---|---|---|
| AHK-Cu | Alanine–histidine–lysine in a copper-complex context | That a GHK-Cu experiment tested this ligand |
| GHK-Cu | Glycine–histidine–lysine in a copper-complex context | That a copper-free GHK result characterizes the complex |
| GHK | The glycine–histidine–lysine peptide | That copper content or complex formation is established by the abbreviation |
| Pal-GHK | A palmitoylated GHK derivative | That modifying the peptide leaves all properties unchanged |
This is an identity comparison, not a ranking of performance. A useful ranking would need a matched experiment with a shared endpoint and suitable controls. Separate studies with different tissues cannot supply that ranking merely because their titles mention copper peptides.
What the AHK-Cu follicle experiment actually examined
Pyo and colleagues studied AHK-Cu in isolated human hair follicles and cultured dermal papilla cells. They observed follicle elongation and increased cell proliferation under the experimental conditions. Their apoptosis measurements were more nuanced: the reduction in apoptotic cells in one assay was not statistically significant, although several associated protein measurements changed. Pyo et al., 2007
That combination matters when summarizing the paper. “The investigators measured follicle and cell responses” is supported. “Every proposed cellular mechanism was confirmed” is not. The experiment also did not compare AHK-Cu directly with GHK-Cu or test a retail preparation in people.
An ex vivo human follicle is human tissue maintained outside the body. It can answer tissue-level questions while leaving distribution, metabolism, long-term exposure, and whole-organism responses unresolved. Describing the tissue as human does not turn the study into a clinical trial.
Why the GHK-Cu wound model answers another question
Maquart and colleagues investigated GHK-Cu using implanted wound chambers in rats. They measured accumulated tissue constituents, including collagen and glycosaminoglycans, and reported changes in extracellular matrix accumulation. This is a specific model of connective-tissue response, rather than a follicle comparison. Maquart et al., 1993
The AHK-Cu and GHK-Cu papers therefore sit on different experimental axes: different materials, different biological systems, and different endpoints. Putting their findings side by side can explain where research has been performed. It cannot establish that one peptide is superior, that their effects are identical, or that they can substitute for each other.
The Recovery Peptides category brings related research materials together for browsing. Its shared category name does not erase these experimental differences.
Reading the copper part of the evidence
There are three separate questions: which peptide is present, how much copper is present, and what chemical species exist in the preparation being examined. A single result may address only one of them. For example, identifying a peptide signal does not by itself characterize every copper-containing species in a solution.
When comparing reports, ask whether both describe the same starting material and whether their methods answer the same question. A measurement made on a dry supplied material and a measurement made after transfer into an assay medium need not describe the same state. This is why copper speciation and assay context deserve separate treatment from peptide naming.
For material documentation, start with the relevant COA and identify what was actually measured. The peptide COA guide explains the difference between an identity result and a purity result. Neither a literature citation nor another product's report can fill a missing measurement for the selected lot.
Research limitations
The primary studies above are selected examples, not a systematic review of every copper-peptide publication. They support model-specific descriptions, not comparative clinical conclusions. They do not establish the identity, composition, stability, or biological activity of materials supplied by NEXTWAVE PEPTIDES.
The most defensible comparison is therefore chemical first and experimental second. A clear distinction between molecules is already useful; there is no need to manufacture a winner from studies that were not designed to identify one.
FAQ
Is AHK-Cu another spelling of GHK-Cu?
No. Alanine and glycine occupy the first sequence position in different peptides. The shared histidine–lysine segment does not remove that difference.
Does the AHK-Cu follicle paper prove a GHK-Cu result?
No. It directly informs the AHK-Cu material and models examined. A claim about GHK-Cu needs evidence testing GHK-Cu.
Is GHK the same material as GHK-Cu?
The labels do not specify the same thing. GHK names the peptide; GHK-Cu adds the copper-complex identity. Documentation should make clear which material was examined.
Can the two copper peptides share one analytical report?
A report applies to the identified sample and lot. It should not be transferred between AHK-Cu and GHK-Cu, even when the method used to analyze them is similar.
Which is better for a research comparison?
That depends on the scientific question. Choose the molecule relevant to that question and evaluate studies with compatible models and endpoints; the two papers discussed here do not establish comparative superiority.